Correlation Between Lifeline Biotechnologies and Hard To

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lifeline Biotechnologies and Hard To at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lifeline Biotechnologies and Hard To into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lifeline Biotechnologies and Hard to Treat, you can compare the effects of market volatilities on Lifeline Biotechnologies and Hard To and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lifeline Biotechnologies with a short position of Hard To. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lifeline Biotechnologies and Hard To.

Diversification Opportunities for Lifeline Biotechnologies and Hard To

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Lifeline and Hard is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Lifeline Biotechnologies and Hard to Treat in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hard to Treat and Lifeline Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lifeline Biotechnologies are associated (or correlated) with Hard To. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hard to Treat has no effect on the direction of Lifeline Biotechnologies i.e., Lifeline Biotechnologies and Hard To go up and down completely randomly.

Pair Corralation between Lifeline Biotechnologies and Hard To

If you would invest  0.03  in Lifeline Biotechnologies on September 23, 2024 and sell it today you would lose (0.02) from holding Lifeline Biotechnologies or give up 66.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy76.61%
ValuesDaily Returns

Lifeline Biotechnologies  vs.  Hard to Treat

 Performance 
       Timeline  
Lifeline Biotechnologies 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Lifeline Biotechnologies are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental drivers, Lifeline Biotechnologies displayed solid returns over the last few months and may actually be approaching a breakup point.
Hard to Treat 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hard to Treat has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Hard To is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Lifeline Biotechnologies and Hard To Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lifeline Biotechnologies and Hard To

The main advantage of trading using opposite Lifeline Biotechnologies and Hard To positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lifeline Biotechnologies position performs unexpectedly, Hard To can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hard To will offset losses from the drop in Hard To's long position.
The idea behind Lifeline Biotechnologies and Hard to Treat pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk